Results 41 to 50 of about 7,578 (214)

Common Variable Immunodeficiency (CVID): A Case Report [PDF]

open access: yes, 2017
Common variable immune deficiency disease is the most prevalent acquired immune deficiency in human being after selective immunoglobulin A deficiency.
Naser Esmaeili   +3 more
core   +4 more sources

CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID [PDF]

open access: yes, 2019
Background: Common variable immunodeficiency disorder (CVID) is one of the most frequent inborn errors of immunity, increased occurrence of malignancies, particularly lymphomas, and gastric cancers, has long been noted among CVID patients. Multifactorial
Jitka Petanova   +16 more
core   +1 more source

Autoimmune Cytopenias in Common Variable Immunodeficiency Are a Diagnostic and Therapeutic Conundrum: An Update

open access: yesFrontiers in Immunology, 2022
Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency (PID). CVID is a heterogenous condition and clinical manifestations may vary from increased susceptibility to infections to autoimmune manifestations ...
Sanchi Chawla   +6 more
doaj   +1 more source

Autoimmunity and infection in common variable immunodeficiency (CVID) [PDF]

open access: yes, 2016
Common variable immunodeficiency (CVID) is a heterogeneous group of diseases, characterized by primary hypogammaglobulinemia. B and T cell abnormalities have been described in CVID.
PATUZZO, Giuseppe   +15 more
core   +1 more source

602 Cvid

open access: yesWorld Allergy Organization Journal, 2012
BACKGROUND: Among the more than 150 different forms of Primary Immunodeficiency Diseases (PID) the CVID is the most common symptomatic primary immunodeficiency, present mainly in adults. There is a failure of B cells to develop and differentiate into plasma cells; at consequent a reduction of the production of one or more isotypes of antibody can also ...
Gallego, Claudia   +7 more
openaire   +1 more source

FoxP3+ Treg cells are reduced in CVID. [PDF]

open access: yes, 2013
(A) Representative staining illustrating the gating strategy used. (B) Comparison of the frequency of Treg cells in healthy controls and CVID patients before IVIg (left panel), and in CVID patients before and after IVIg (right panel).
Jorge Kalil (52916)   +9 more
core   +1 more source

The Dysfunctional Immune System in Common Variable Immunodeficiency Increases the Susceptibility to Gastric Cancer

open access: yesCells, 2020
Gastric carcinoma (GC) represents the most common cause of death in patients with common variable immunodeficiency (CVID). However, a limited number of cases have been characterised so far.
Irene Gullo   +16 more
doaj   +1 more source

Investigating pulmonary and non-infectious complications in common variable immunodeficiency disorders: a UK national multi-centre study

open access: yesFrontiers in Immunology
BackgroundCommon Variable Immunodeficiency Disorders (CVID) encompass a spectrum of immunodeficiency characterised by recurrent infections and diverse non-infectious complications (NICs).
Heba M. Bintalib   +22 more
doaj   +1 more source

Global Distribution of Common Variable Immunodeficiency (CVID) in the Light of the UNDP Human Development Index (HDI): A Preliminary Perspective of a Rare Disease

open access: yesJournal of Immunology Research, 2020
Common variable immunodeficiency (CVID), although the most common primary immunodeficiency in humans, is a rare disease. We explored the spatial global distribution and country-wise prevalence of CVID, based on published data and those available from ...
Niels Weifenbach   +2 more
doaj   +1 more source

Assessment of the first presentations of common variable immunodeficiency in a large cohort of patients

open access: yesBMC Immunology, 2023
Background Common Variable Immunodeficiency (CVID) is a primary immunodeficiency syndrome resulting in recurrent infections, autoimmunity, and granulomatous manifestations.
Hossein Esmaeilzadeh   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy